Loading...

AVBP ARRIVENT BIOPHARMA INC Management Changes 8-K Filing

RRVN

VBP

ARRIVENT BIOPHARMA INC

(AVBP)

2025 8-K

Stock Offering Update

Financial Results Released

Presentation Announcement

Financial Results Report

Financial Results Announcement

Data Presentation

Product Expansion

Equity Offerings

Product Expansion

Financial Statements

Accounting Firm Change

Financial Results

License Agreement

Q3 Financial Results

Positive Trial Results

External Links:

On June 18, 2025, ArriVent BioPharma, Inc. held its annual meeting where shareholders elected new directors and ratified PricewaterhouseCoopers as the auditor for the year. Out of 34 million shares, approximately 73.89% participated in the vote.

AI Assistant

ARRIVENT BIOPHARMA INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.